175 related articles for article (PubMed ID: 20455857)
1. The acquired deficiency of C1-inhibitor: lymphoproliferation and angioedema.
Cicardi M; Zanichelli A
Curr Mol Med; 2010 Jun; 10(4):354-60. PubMed ID: 20455857
[TBL] [Abstract][Full Text] [Related]
2. The Janus faces of acquired angioedema: C1-inhibitor deficiency, lymphoproliferation and autoimmunity.
Wu MA; Castelli R
Clin Chem Lab Med; 2016 Feb; 54(2):207-14. PubMed ID: 26068904
[TBL] [Abstract][Full Text] [Related]
3. Angioedema due to acquired C1-inhibitor deficiency: a bridging condition between autoimmunity and lymphoproliferation.
Cugno M; Castelli R; Cicardi M
Autoimmun Rev; 2008 Dec; 8(2):156-9. PubMed ID: 19014872
[TBL] [Abstract][Full Text] [Related]
4. [Acquired C1 esterase inhibitor deficiency via bradykinin-mediated angioedema: Four cases].
Jacquin-Porretaz C; Castelain F; Daguindau E; Seilles E; Nardin C; Aubin F; Pelletier F
Ann Dermatol Venereol; 2018 Oct; 145(10):598-602. PubMed ID: 29673745
[TBL] [Abstract][Full Text] [Related]
5. Lymphoproliferative disease and acquired C1 inhibitor deficiency.
Castelli R; Deliliers DL; Zingale LC; Pogliani EM; Cicardi M
Haematologica; 2007 May; 92(5):716-8. PubMed ID: 17488706
[TBL] [Abstract][Full Text] [Related]
6. Acquired C1 Inhibitor Deficiency.
Otani IM; Banerji A
Immunol Allergy Clin North Am; 2017 Aug; 37(3):497-511. PubMed ID: 28687105
[TBL] [Abstract][Full Text] [Related]
7. Angioedema due to acquired C1-inhibitor deficiency: spectrum and treatment with C1-inhibitor concentrate.
Bork K; Staubach-Renz P; Hardt J
Orphanet J Rare Dis; 2019 Mar; 14(1):65. PubMed ID: 30866985
[TBL] [Abstract][Full Text] [Related]
8. Acquired C1-inhibitor deficiency and lymphoproliferative disorders: a tight relationship.
Castelli R; Zanichelli A; Cicardi M; Cugno M
Crit Rev Oncol Hematol; 2013 Sep; 87(3):323-32. PubMed ID: 23490322
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic options for patients with angioedema due to C1-inhibitor deficiencies: from pathophysiology to the clinic.
Castelli R; Zanichelli A; Cugno M
Immunopharmacol Immunotoxicol; 2013 Feb; 35(1):181-90. PubMed ID: 23137231
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis, Course, and Management of Angioedema in Patients With Acquired C1-Inhibitor Deficiency.
Zanichelli A; Azin GM; Wu MA; Suffritti C; Maggioni L; Caccia S; Perego F; Vacchini R; Cicardi M
J Allergy Clin Immunol Pract; 2017; 5(5):1307-1313. PubMed ID: 28284781
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies and lymphoproliferative diseases in acquired C1-inhibitor deficiencies.
Cicardi M; Zingale LC; Pappalardo E; Folcioni A; Agostoni A
Medicine (Baltimore); 2003 Jul; 82(4):274-81. PubMed ID: 12861105
[TBL] [Abstract][Full Text] [Related]
12. Relevance of lymphoproliferative disorders and of anti-C1 inhibitor autoantibodies in acquired angio-oedema.
Cicardi M; Beretta A; Colombo M; Gioffré D; Cugno M; Agostoni A
Clin Exp Immunol; 1996 Dec; 106(3):475-80. PubMed ID: 8973615
[TBL] [Abstract][Full Text] [Related]
13. C1-inhibitor (C1-INH) autoantibodies in hereditary angioedema. Strong correlation with the severity of disease in C1-INH concentrate naïve patients.
Varga L; Széplaki G; Visy B; Füst G; Harmat G; Miklós K; Németh J; Cervenak L; Karádi I; Farkas H
Mol Immunol; 2007 Feb; 44(6):1454-60. PubMed ID: 16750855
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of C1-inhibitor deficiency.
Pappalardo E; Zingale LC; Terlizzi A; Zanichelli A; Folcioni A; Cicardi M
Immunobiology; 2002 Sep; 205(4-5):542-51. PubMed ID: 12396014
[TBL] [Abstract][Full Text] [Related]
15. C1-inhibitor deficiency and angioedema.
Carugati A; Pappalardo E; Zingale LC; Cicardi M
Mol Immunol; 2001 Aug; 38(2-3):161-73. PubMed ID: 11532278
[TBL] [Abstract][Full Text] [Related]
16. Serum complexes between C1INH and C1INH autoantibodies for the diagnosis of acquired angioedema.
López-Lera A; Garrido S; Nozal P; Skatum L; Bygum A; Caballero T; López Trascasa M
Clin Exp Immunol; 2019 Dec; 198(3):341-350. PubMed ID: 31397881
[TBL] [Abstract][Full Text] [Related]
17. C1-inhibitor deficiency and angioedema: molecular mechanisms and clinical progress.
Cugno M; Zanichelli A; Foieni F; Caccia S; Cicardi M
Trends Mol Med; 2009 Feb; 15(2):69-78. PubMed ID: 19162547
[TBL] [Abstract][Full Text] [Related]
18. Splenic marginal zone lymphomas in acquired C1-inhibitor deficiency: clinical and molecular characterization.
Sbattella M; Zanichelli A; Ghia P; Gattei V; Suffritti C; Teatini T; Cicardi M; Castelli R
Med Oncol; 2018 Aug; 35(9):118. PubMed ID: 30073422
[TBL] [Abstract][Full Text] [Related]
19. Hereditary and acquired C1-inhibitor-dependent angioedema: from pathophysiology to treatment.
Zeerleder S; Levi M
Ann Med; 2016; 48(4):256-67. PubMed ID: 27018196
[TBL] [Abstract][Full Text] [Related]
20. The acquired C1-INH deficiencies with autoantibodies (AAE type II).
Alsenz J; Loos M
Behring Inst Mitt; 1989 Jul; (84):165-72. PubMed ID: 2679532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
